Endothelins: Effect on matrix biosynthesis and proliferation in normal and scleroderma fibroblasts

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 1, 1998, Pages

  Xu, Shi Wen ^a   Denton, C P ^a   Holmes, A ^a   Dashwood, M R ^a   Abraham, D J ^a   Black, C M ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Collagens; Endothelin 1; Fibroblasts; Scleroderma

Indexed keywords

COLLAGEN; COLLAGENASE; DNA; ENDOTHELIN; INTERSTITIAL COLLAGENASE; SCLEROPROTEIN;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; DRUG EFFECT; FEMALE; FIBROBLAST; HUMAN; MALE; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION; SYSTEMIC SCLEROSIS;

CELL DIVISION; CELLS, CULTURED; COLLAGEN; COLLAGENASES; DNA; ENDOTHELINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; POLYMERASE CHAIN REACTION; SCLERODERMA, SYSTEMIC;

EID: 0031629184     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800001-00101     Document Type: Article

References (8)

1. Rubanyi GM, Polokoff MA. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
2. Kahaleh MB. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Arthritis Rheum 34:978-83.
3. Guarda E, Katwa LC, Myers PR, Tyagi SC, Weber KT. Effects of endothelins on collagen turnover in cardiac fibroblasts. Cardiovasc Res 1993;27:2130-4.
4. Black CM. Scleroderma - clinical aspects. J Int Med 1993;234: 115-8.
5. Knock GA, Terenghi G, Bunker CB, Bull HA, Dowd PM, Polak JM. Characterisation of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis. J Invest Dermatol 1993;101:73-8.
6. Vancheeswaran R, Magoulas T, Efrat G, Olsen IO, Penny RM, Black CM. Circulating endothelin-1 levels suggest different pathogenic mechanisms in systemic sclerosis (SSc) subsets. J Rheumatol 1994;21:1838-44.
7. Abraham DJ, Vancheeswaran R, Dashwood MR, et al. Increased levels of ET-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol 1997;151:831-44.
8. Shi-Wen X, Vancheeswaran R, Bou-Gharios G, et al. Scleroderma-derived human fibroblasts retain abnormal phenotypic and functional characteristics following retroviral transduction with the SV40 tsT antigen. Exp Cell Res 1995;220:407-14.